Official European Society of Oncology Pharmacy Blog

24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomised, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information. For these reasons, the Symposium has been organised to ensure the maximum amount of interaction and discussion through an exciting range of plenary sessions and lively workshops.

Plenary Sessions:

  1. Changing Landscape of Clinical Trial Design: Small Studies, Large Differences
  2. Proffered Paper Session
  3. Biomarkers for Antitumour Evaluation
  4. Next Generation Gene Sequencing: how to use?
  5. Drug Dosing
  6. Proffered Paper Session
  7. Microenvironment
  8. Drug Resistance in Targeted Agents

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


This entry was posted on November 26, 2012 by .

ESOP Facebook!

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 25 other subscribers

ESOP webpage!

%d bloggers like this: